Real-world analysis of the PK-guided switch from standard half-life factor VIII to efmoroctocog alfa

Thromb Res. 2024 Jan:233:135-137. doi: 10.1016/j.thromres.2023.11.023. Epub 2023 Nov 23.
No abstract available

Keywords: Efmoroctocog alfa; Hemophilia; Personalized prophylaxis; Pharmacokinetics; WAPPS-Hemo.

Publication types

  • Letter

MeSH terms

  • Factor VIII / therapeutic use
  • Half-Life
  • Hemophilia A* / drug therapy
  • Hemostatics*
  • Humans

Substances

  • Factor VIII
  • Hemostatics